Interferon-β induces hepatocyte growth factor in monocytes of multiple sclerosis patients.

Interferon-β induces hepatocyte growth factor in monocytes of multiple sclerosis patients.

Interferon-β is a first-line therapy used to prevent relapses in relapsing-remitting multiple sclerosis. The clinical benefit of interferon-β in relapsing-remitting multiple sclerosis is attributed to its immunomodulatory effects on inflammatory mediators and T cell reactivity. Here, we evaluated th...

Full description

Bibliographic Details
Main Authors: Nicolas Molnarfi, Mahdia Benkhoucha, Kristbjörg Bjarnadóttir, Catherine Juillard, Patrice H Lalive
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3498184?pdf=render

Internet

http://europepmc.org/articles/PMC3498184?pdf=render

Similar Items